(“Vivos” or the “Company’’) (NASDAQ: VVOS), a leading medical device and healthcare services company focused on the treatment of breathing related sleep disorders and associated chronic health ...

Most hypnotics (sleep medications) for insomnia (sleep disorder) do not worsen obstructive sleep apnea but emphasize the need ...

Researchers found that the medication sulthiame reduced breathing interruptions and improved oxygen levels overnight in people with moderate to severe sleep apnea. The findings were published recently ...

Incannex Healthcare Inc. (NASDAQ:IXHL) on Thursday detailed an updated clinical development plan for IHL-42X, its oral ...

A study of nearly one million US veterans finds that people with both insomnia and sleep apnea face sharply higher risks of ...

A European clinical trial found that the drug sulthiame significantly reduced breathing interruptions in people with moderate ...

Nearly a quarter of people in a global analysis of Samsung Health users showed indicators associated with sleep apnea risk, ...

More than 80% of patients implanted with a transvenous phrenic nerve stimulation device for central sleep apnea had at least ...

A European clinical trial found that sulthiame, a drug used in the treatment of epilepsy, reduced breathing interruptions.

Sleep apnea affects over 29 million Americans, with Obstructive Sleep Apnea (characterized by pauses in breathing during sleep) being the most common form. A recent study suggests that taking a daily ...

With more than one in 10 Americans facing an increased risk of stroke, heart attack and high blood pressure because of untreated sleep apnea, a new University of Maryland School of Medicine study ...

Researchers believe that a drug used to treat childhood epilepsy may also be good for assisting with sleep apnea-related ...